| CTRI Number |
CTRI/2026/01/101022 [Registered on: 14/01/2026] Trial Registered Prospectively |
| Last Modified On: |
05/01/2026 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Other (Specify) [Dietary protocol] |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Effect of a millet-based diet in quality of life in cancer patients |
|
Scientific Title of Study
|
Impact of a Low-Grain therapeutic diet on nutritional status, symptoms and quality of life in cancer patients: A Quasi-experimental study |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Pradeep M K Nair |
| Designation |
Medical Director & Chief Scientist |
| Affiliation |
Mirakle Integrated Health Centre |
| Address |
Department of Integrative Oncology,
Room No:1,
Mirakle Integrated Health Centre, NPTC-MCET Campus, Udumalai Road, Pollachi
Coimbatore TAMIL NADU 642003 India |
| Phone |
|
| Fax |
|
| Email |
research@mirakleihc.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Pradeep M K Nair |
| Designation |
Medical Director & Chief Scientist |
| Affiliation |
Mirakle Integrated Health Centre |
| Address |
Department of Integrative Oncology,
Room No: 1,
Mirakle Integrated Health Centre, NPTC-MCET Campus, Udumalai Road, Pollachi
Coimbatore TAMIL NADU 642003 India |
| Phone |
|
| Fax |
|
| Email |
research@mirakleihc.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Pradeep M K Nair |
| Designation |
Medical Director & Chief Scientist |
| Affiliation |
Mirakle Integrated Health Centre |
| Address |
Department of Integrative Oncology,
Room No:1,
Mirakle Integrated Health Centre, NPTC-MCET Campus, Udumalai Road, Pollachi
Coimbatore TAMIL NADU 642003 India |
| Phone |
|
| Fax |
|
| Email |
research@mirakleihc.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
Mirakle Integrated Health Centre |
| Address |
NPT-MCET Campu, Udumalai road, Pollachi, Tamil Nadu, India.
Pincode: 642003 |
| Type of Sponsor |
Private hospital/clinic |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Pradeep MK Nair |
Mirakle Integrated Health Centre |
Department of Integrative Oncology,
Room No: 1,
NPT-MCET Campus,
Udumalai road,
Pollachi - 642003. Coimbatore TAMIL NADU |
8667483682
research@mirakleihc.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Mirakle Integrated Health Centre |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: C00-D49||Neoplasms, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Low grain diet |
Cancer patients are put under low grain diet for at least 24 or more. On discharge a diet chart will be provided to follow for 3 months until next assessment |
| Comparator Agent |
NA |
NIL |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
80.00 Year(s) |
| Gender |
Both |
| Details |
Cancer patients who are aged between 18 to 80 years and oral food intake is possible. Patients who are willing and able to give informed consent |
|
| ExclusionCriteria |
| Details |
Cancer patients who are below 18 years of and oral intake is not possible. Patient who are on nasogastric tube feeding or surgery involving GI tract, like gastrectomy etc. Also patient who are unable to give consent in due to mental illness are excluded |
|
|
Method of Generating Random Sequence
|
Other |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| PG-SGA total score |
Baseline (at the start of treatment)
After 24 days of treatment
After 3 months
|
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
Anthropometric assessments
Biochemical parameters (LFT, Total protein, Hb, HbA1c, Vitamin D, Vitamin B12, LDH & Ferritin )
Edmonton Symptom Assessment Scale
Chuangs prognosis scale |
Baseline, after 24 days treatment & after 3 months follow up |
|
|
Target Sample Size
|
Total Sample Size="40" Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
16/01/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Cancer and its treatment often lead to poor nutrition, weight loss, and reduced quality of life in patients. Proper dietary support may help improve nutritional status and overall well being. Millets are nutrient rich, low glycemic grains that can be used as part of a supportive diet for cancer patients. The Mirakle low grain diet protocol is designed to meet the nutritional needs of cancer patients and is easy to digest and culturally acceptable. This study aims to evaluate the effect of a structured one month low grain diet protocol on nutritional status and quality of life in hospitalized cancer patients and to assess whether these benefits are sustained at three months after discharge. The hypothesis of the study is that the low grain diet protocol will improve nutritional status and quality of life in cancer patients, with sustained benefits observed at follow up. |